Skip to main content
70°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Processa Pharmaceuticals Inc
(NQ:
PCSA
)
1.380
-0.010 (-0.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Processa Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
What's Going On With Anti Cancer Focused Processa Pharmaceuticals Stock Today?
January 26, 2024
Processa Pharmaceuticals stock surge - 148.8% gain to $5.10 post Next Generation Capecitabine (NGC-Cap) Phase 1b success.
Via
Benzinga
Intel, Nvidia, AMD, Processa Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 25, 2024
Via
Benzinga
Nasdaq Edges Lower; American Airlines Posts Upbeat Earnings
January 25, 2024
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.25% to 37,900.45 while the NASDAQ fell 0.13% to 15,462.53. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?
January 25, 2024
Processa Pharmaceuticals successfully completed its safety trial for a key cancer drug. Now, PCSA stock is soaring on the positive implications.
Via
InvestorPlace
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 25, 2024
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.
Via
Benzinga
Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results
January 25, 2024
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday. The Dow traded up 0.06% to 37,829.32 while the NASDAQ rose 0.22% to 15,515.62. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
January 25, 2024
Via
Benzinga
Why Processa Pharmaceuticals Stock Is Soaring
January 25, 2024
Processa Pharmaceuticals shares are soaring Thursday after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Processa...
Via
Benzinga
Exposures
Product Safety
Dow Surges Over 100 Points; US GDP Growth Tops Estimates
January 25, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.33% to 37,932.33 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 22, 2024
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the...
Via
Benzinga
US Stocks Higher; Nasdaq Jumps 100 Points
January 22, 2024
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded up 0.55% to 38,073.10 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500 Gains 1%; State Street Reports Upbeat Earnings
January 19, 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.95% to 37,824.10 while the NASDAQ rose 1.39% to 15,264.30. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Jumps 150 Points; US Consumer Sentiment Surges In January
January 19, 2024
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Friday. The Dow traded up 0.41% to 37,621.27 while the NASDAQ rose 0.66% to 15,154.43. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Processa Pharmaceuticals (PCSA) Stock Is Skyrocketing
January 19, 2024
Processa Pharmaceuticals shares are trading higher by 36.9% during Friday's session. The company announced plans to expand the development of Next Generation Capecitabine.
Via
Benzinga
US Stocks Higher; Schlumberger Earnings Beat Estimates
January 19, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.18% to 37,536.76 while the NASDAQ rose...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 19, 2024
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode...
Via
Benzinga
Dow Surges Over 100 Points; M&T Bank Posts Weak Earnings
January 18, 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.35% to 37,398.50 while the NASDAQ rose 1.16% to 15,027.63....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 18, 2024
Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 18, 2024
Via
Benzinga
Crude Oil Rises Over 1%; Processa Pharmaceuticals Shares Slide
January 18, 2024
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 1% on Thursday. The Dow traded down 0.02% to 37,257.79 while the NASDAQ rose 1.19% to 15,032.26. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Processa Pharmaceuticals (PCSA) Shares Are Nosediving
January 18, 2024
Processa Pharmaceuticals shares are trading lower by 23% during Thursday's session. The company announced it will effect a 1-for-20 reverse stock split.
Via
Benzinga
Nasdaq Jumps Over 100 Points; US Jobless Claims Fall To 187,000
January 18, 2024
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.33% to 37,143.30 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 29, 2023
Via
Benzinga
Why Rocket Lab Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
December 22, 2023
Shares of Rocket Lab USA, Inc. (NASDAQ: RKLB) shares rose sharply in pre-market trading after the company announced a new $515 million contract with a U.S. government customer.
Via
Benzinga
Processa Pharmaceuticals Innovative Cancer Treatment Demonstrates Higher Efficacy at Lower Doses Over Capecitabine
December 19, 2023
Processa Pharmaceuticals Inc (NASDAQ: PCSA) provides an interim analysis from its Phase 1b
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 19, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.